Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

COUCH Medcomms

Biogen Idec building

Biogen and AbbVie pull MS drug Zinbryta from the market

Potential risks of liver damage and immune-related conditions have been reported

Gilead Sciences

Gilead study resurrects HIV eradication hope

Intends to start human trials of its improved bNAb candidate

Alexion Pharmaceuticals adds to its board

Judith Reinsdorf recently worked at Johnson Controls

Implementing eHealth innovation

How Merck’s PMEA-winning progress in new technology  is improving outcomes for young patients

- PMLiVE

Lighthouse Medical Communications US bolster their senior scientific team

Lighthouse Medical Communications US, part of the award-winning Lucid Group of companies, is pleased to announce the appointment of Marc Pondel, PhD as Executive Medical Science Director. Marc will oversee...

Lucid Group Communications Limited

- PMLiVE

Merck and Pfizer set to win NICE backing for Bavencio

The PD-L1 inhibitor is being assessed for the treatment of mMCC patients

- PMLiVE

Novo launches $165m antimicrobial resistance initiative

The REPAIR Fund will support groups looking to combat antibiotic resistance

translational pharmacology medicine dose

UK government updates the Model Clinical Trials Agreement

New regulation aims to speed-up R&D

- PMLiVE

Three Publicis Health agencies unveils new campaign

The animation showcases Publicis LifeBrands, Publicis Resolute and Real Science

Microsoft brings its AI network to cardiology

Also launches cloud-based genomics service for its Azure platform

Roche Basel Switzerland

Roche wins European approval for bleeding disorder treatment Hemlibra

It's the first new medicine in over 20 years to treat patients with inhibitors

- PMLiVE

Pharma sales help Bayer escape the worst from a bumpy 2017

But the German pharma firm reins in expectations for this year

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links